0
0 (0%)
Emmaus Life Sciences, Inc. [EXMWW]
Source:
Company Overview
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of innovative treatments and therapies, primarily for rare and orphan diseases.
| Country | United States |
| Headquarters | torrance, california |
| Phone Number | 310-214-0065 |
| Industry | manufacturing |
| CEO | Willis C. Lee, M.S. |
| Website | www.emmausmedical.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $16.7 |
| Operating Profit | $-1.9 |
| Net Income | $-6.5 |
| Net Cash | $-1.2 |
Profit Ratios
| Gross Margin | $15.5 |
| Operating Margin | -11.4 |
| Profit as % of Revenues | -239.5% |
| Profit as % of Assets | -22% |
| Profit as % of Stockholder Equity | 11.4% |
Management Effectiveness
| Return on Equity | 11.4% |
| Return on Assets | -27.3% |
| Turnover Ratio | 56.7% |
| EBITA | $-1.9 |
Balance Sheet and Cash Flow Measures
| Total Assets | $23.6 |
| Total Liabilities | $80.1 |
| Operating Cash Flow | $-2.3 |
| Investing Cash Flow | $2.5 |
| Financing Cash Flow | $-1.4 |
